Cort S Madsen is a notable inventor based in West Windsor, NJ (US), recognized for his contributions to medical science, particularly in the field of renal function. With a total of five patents to his name, Madsen has made significant strides in developing innovative treatments for kidney failure and related cardiovascular conditions.

Latest Patents

Madsen's latest patents focus on methods of treating kidney failure and improving or stabilizing renal function using modified relaxin polypeptides. These patents detail the use of modified human relaxin 2 polypeptides, which include a non-naturally encoded amino acid linked to a pharmacokinetic enhancer. The therapeutic applications of these polypeptides extend to treating cardiovascular conditions, such as heart failure, and addressing issues related to fibrosis.

Career Highlights

Cort S Madsen has established a successful career at Bristol-Myers Squibb Company, where he has been instrumental in advancing research and development in therapeutic solutions. His work has not only contributed to the scientific community but has also paved the way for new treatment options for patients suffering from serious health conditions.

Collaborations

Madsen has collaborated with esteemed colleagues, including Gene Michael Dubowchik and Olafur S Gudmundsson, to further enhance the impact of his research. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Cort S Madsen's innovative work in the realm of renal function treatments exemplifies the importance of research and development in medicine. His contributions continue to influence the landscape of therapeutic options available for patients today.

Profile summary based on public USPTO records.